PLoS ONE · 2015 · 60 citations · 26 references
PharmacyPharmacologyToxicologyAnalytical ToxicologyFish BiologyPharmaceutical ToxicologyBioanalytical Method ValidationFish ToxicologyPreclinical Drug EvaluationPreclinical Toxicity TestingToxicological Drug ScreeningToxicological Screening Of PharmaceuticalsAcute Drug ToxicityDrug Screening AssaysDrug Toxicity ModelsDrug Toxicity TestingLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisMultiple Reaction MonitoringTandem Mass Spectrometry
Evaluation of drug toxicity is necessary for drug safety, but in vivo drug absorption is varied; therefore, a rapid, sensitive and reliable method for measuring drugs is needed. Zebrafish are acceptable drug toxicity screening models; we used these animals with a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method in a multiple reaction monitoring mode to quantify drug uptake in zebrafish to better estimate drug toxicity. Analytes were recovered from zebrafish homogenate by collecting supernatant. Measurements were confirmed for drugs in the range of 10-1,000 ng/mL. Four antibiotics with different polarities were tested to explore any correlation of drug polarity, absorption, and toxicity. Zebrafish at 3 days post-fertilization (dpf) absorbed more drug than those at 6 h post-fertilization (hpf), and different developmental periods appeared to be differentially sensitive to the same compound. By observing abnormal embryos and LD50 values, zebrafish embryos at 6 hpf were considered to be suitable for evaluating embryotoxicity. Also, larvae at 3 dpf were adapted to measure acute drug toxicity in adult mammals. Thus, we can exploit zebrafish to study drug toxicity and can reliably quantify drug uptake with LC-MS/MS. This approach will be helpful for future studies of toxicology in zebrafish.
26
The zebrafish reference genome sequence and its relationship to the human genome
Kerstin Howe, Matthew D. Clark, Carlos Torroja et al. · Nature · 2013 · 5.1K citations · Full text
Life Sciences, Biology, Genetics +17
Screening for human ADME/Tox drug properties in drug discovery
Albert P. Li · Drug Discovery Today · 2001 · 538 citations
Spending on new drug development1
Christopher Adams, Van V. Brantner · Health Economics · 2009 · 274 citations